Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Green Cross Cell Corporation

ClinicalTrials.gov Identifier:

NCT00807027

First received: December 10, 2008

Last updated: October 24, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2012
Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)